R1 RCM Inc. (NASDAQ:RCM) Shares Bought by Bardin Hill Management Partners LP

Bardin Hill Management Partners LP lifted its stake in shares of R1 RCM Inc. (NASDAQ:RCMFree Report) by 2.0% in the 3rd quarter, Holdings Channel reports. The fund owned 535,939 shares of the healthcare provider’s stock after acquiring an additional 10,728 shares during the quarter. R1 RCM accounts for approximately 3.5% of Bardin Hill Management Partners LP’s investment portfolio, making the stock its 10th biggest position. Bardin Hill Management Partners LP’s holdings in R1 RCM were worth $7,594,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in RCM. GAMMA Investing LLC boosted its stake in R1 RCM by 41.3% in the 3rd quarter. GAMMA Investing LLC now owns 2,597 shares of the healthcare provider’s stock worth $37,000 after purchasing an additional 759 shares during the period. Arizona State Retirement System boosted its position in shares of R1 RCM by 2.1% during the second quarter. Arizona State Retirement System now owns 47,063 shares of the healthcare provider’s stock worth $591,000 after buying an additional 969 shares during the period. QRG Capital Management Inc. grew its holdings in shares of R1 RCM by 10.6% during the second quarter. QRG Capital Management Inc. now owns 11,307 shares of the healthcare provider’s stock worth $142,000 after buying an additional 1,080 shares in the last quarter. Victory Capital Management Inc. grew its holdings in shares of R1 RCM by 7.7% during the second quarter. Victory Capital Management Inc. now owns 36,006 shares of the healthcare provider’s stock worth $452,000 after buying an additional 2,574 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its position in R1 RCM by 589.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,122 shares of the healthcare provider’s stock valued at $44,000 after buying an additional 2,669 shares during the last quarter. 61.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

RCM has been the subject of a number of recent research reports. Truist Financial reduced their price target on R1 RCM from $16.00 to $14.30 and set a “hold” rating for the company in a research report on Thursday, August 8th. Morgan Stanley cut shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 8th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $14.30 target price on shares of R1 RCM in a research report on Friday, October 4th. Finally, TD Cowen reissued a “hold” rating and set a $14.30 price target (down from $20.00) on shares of R1 RCM in a research report on Monday, August 5th. Thirteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, R1 RCM has an average rating of “Hold” and an average target price of $15.41.

View Our Latest Report on RCM

R1 RCM Stock Up 0.1 %

Shares of RCM stock opened at $14.31 on Monday. R1 RCM Inc. has a 52-week low of $8.87 and a 52-week high of $15.12. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.79 and a current ratio of 1.79. The stock has a market cap of $6.04 billion, a price-to-earnings ratio of -95.39 and a beta of 0.84. The firm’s 50-day moving average is $14.25 and its 200-day moving average is $13.54.

R1 RCM (NASDAQ:RCMGet Free Report) last released its quarterly earnings data on Tuesday, November 5th. The healthcare provider reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04). The business had revenue of $656.80 million during the quarter, compared to analyst estimates of $640.93 million. R1 RCM had a negative net margin of 2.48% and a negative return on equity of 2.18%. The firm’s revenue for the quarter was up 14.7% compared to the same quarter last year. Sell-side analysts predict that R1 RCM Inc. will post -0.18 EPS for the current year.

R1 RCM Profile

(Free Report)

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.

Featured Stories

Want to see what other hedge funds are holding RCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for R1 RCM Inc. (NASDAQ:RCMFree Report).

Institutional Ownership by Quarter for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.